PHILADELPHIA, PA—Dapagliflozin added to optimal medical therapy results in meaningful improvements in symptoms and health-related quality of life in heart failure patients with reduced ejection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback